16.07.2024 • News
CordenPharma Invests €900 Million in Peptide Platform Expansion
CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform.
Michael Quirmbach
Expert Interview: Michael Quirmbach, CordenPharma
So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has uncovered problems that have been smoldering beneath the surface and need to be addressed. That supply chains are vulnerable to disruption when major development, production and transportation hubs are blocked or shut down has become painfully obvious.
06.12.2016 • Topics • Innovation
The Winning Formula
